|

AI-Driven Early Detection of Skin Cancer

RECRUITINGSponsored by Nuvana Healthcare LTD
Actively Recruiting
SponsorNuvana Healthcare LTD
Started2025-10-01
Est. completion2025-12-01
Eligibility
Age18 Months+
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT07144306

Summary

This study evaluates the feasibility and accuracy of an AI-powered mobile platform (NuvanaDx) for early detection of skin cancer, including melanoma, using smartphone-based imaging. The platform is designed to improve access to early diagnosis, reduce waiting times, and support triage into appropriate care pathways.

Eligibility

Age: 18 Months+Healthy volunteers accepted
Inclusion Criteria:

Adults (≥18 years) presenting with skin lesions suspicious for malignancy.

Ability to provide informed consent.

Exclusion Criteria:

Inability to provide informed consent.

Poor-quality images unsuitable for AI analysis.

Conditions2

CancerSkin Cancer Melanoma

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.